Akenroye A, Nopsopon T, Cho L, Moll M, et al. Lower myostatin and higher MUC1 levels are associated with better response to mepolizumab and omalizumab in asthma: a protein-protein interaction analyses. Respir Res 2023;24:305.
PMID: 38057814